EICHOR

Recruiting studies: Eczema Atopic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dietary Intervention on Atopy
NA · 1 location(s) · National University of Singapore · NCT06547372 Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00605878 Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Phase 3 · 30 location(s) · medac GmbH · NCT06239311 A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in
Phase 3 · 148 location(s) · AbbVie · NCT06461897 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · 46 location(s) · Organon and Co · NCT07265479 A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and E
Phase 1 · 2 location(s) · Chong Kun Dang Pharmaceutical · NCT07358156 Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · 15 location(s) · TRex Bio, Inc. · NCT06934252 Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · 16 location(s) · Oneness Biotech Co., Ltd. · NCT06397911 Ethnic Differences in Mechanisms of Action of Dupilumab
Phase 4 · 1 location(s) · University of Michigan · NCT05268107 Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · 12 location(s) · Alphyn Biologics · NCT06855745 Molecular Signatures of Cutaneous Dupilumab Response
Phase 4 · 1 location(s) · University of California, San Francisco · NCT05858619 A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
Phase 1 · 2 location(s) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · NCT07488065 Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07262983 Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
Phase N/A · 2 location(s) · University Hospital Schleswig-Holstein · NCT07444801 A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Indi
NA · 1 location(s) · ChinaNorm · NCT07022288 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · 59 location(s) · Sanofi · NCT07290803 Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411 A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic De
Phase 2 · 24 location(s) · Hoffmann-La Roche · NCT07223697 Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06801821 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream
Phase N/A · 1 location(s) · Incyte Corporation · NCT06627335 Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NA · 1 location(s) · NAOS Les Laboratoires · NCT06756438 National Register of Moderate and Severe Adult Atopic Dermatitis
Phase N/A · 1 location(s) · Societa Italiana di Dermatologia Medica, Chirurgica, Estetic · NCT06313333 A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641 Natural History and Genetics of Food Allergy and Related Conditions
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02504853 Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390696 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · 150 location(s) · Sanofi · NCT06241118 Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
Phase 3 · 1 location(s) · Jiangsu vcare pharmaceutical technology co., LTD · NCT07592585 A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
Phase 1 · 1 location(s) · Jiangsu Genscend Biopharmaceutical Co., Ltd · NCT07411755 A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
Phase 2 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07330934 PALLAS Laser for Skin Diseases
NA · 1 location(s) · Szeged University · NCT07250997

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →